Tolerability and Safety Study of Recombinant Human Acid Sphingomyelinase in Acid Sphingomyelinase Deficiency Patients
Clinical trial NCT01722526 · COMPLETED
Trial details
- NCT number
- NCT01722526
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-01-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.